Activity of irofulven (6-hydroxymethylacylfulvene) in the treatment of glioblastoma multiforme-derived xenografts in athymic mice

Author： Friedman Henry   Keir Stephen   Houghton Peter   Lawless Amy   Bigner Darell   Waters Stephen  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.48, Iss.5, 2001-11, pp. : 413-416

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Combined Thalidomide and Temozolomide Treatment in Patients with Glioblastoma Multiforme

By Baumann Fabian   Bjeljac Miroslava   Kollias Spyros   Baumert Brigitta   Brandner Sebastian   Rousson Valentin   Yonekawa Yasuhiro   Bernays René  

Journal of Neuro-Oncology, Vol. 67, Iss. 1-2, 2004-03 ,pp. : 191-200

Springer Publishing Company

Access to resources Recommend Favorite

The Combination of Adenoviral HSV TK Gene Therapy and Radiation is Effective in Athymic Mouse Glioblastoma Xenografts without Increasing Toxic Side Effects

By Nestler Ulf   Wakimoto Hiroaki   Siller-Lopez Fernando   Aguilar Laura   Chakravarti Arnab   Muzikansky Alona   Stemmer-Rachamimov Anat   Antonio Chiocca E.   Aguilar-Cordova Estuardo   Hochberg Fred  

Journal of Neuro-Oncology, Vol. 67, Iss. 1-2, 2004-03 ,pp. : 177-188

Springer Publishing Company

Access to resources Recommend Favorite

Enhanced antitumour activity of 6-hydroxymethylacylfulvene in combination with topotecan or paclitaxel in the MV522 lung carcinoma xenograft model

By Hammond L.A.   Hilsenbeck S.G.   Eckhardt S.G.   Marty J.   Mangold G.   MacDonald J.R.   Rowinsky E.K.   Von Hoff D.D.   Weitman S.  

European Journal of Cancer, Vol. 36, Iss. 18, 2000-12 ,pp. : 2430-2436

Elsevier

Access to resources Recommend Favorite

Glioblastoma multiforme: Molecular characterization and current treatment strategy (Review)

By Zhang Xiang   Zhang Wei   Cao Wei-Dong   Cheng Gang   Zhang Yong-Qiang  

Experimental and Therapeutic Medicine, Vol. 3, Iss. 1, 2012-01 ,pp. : 9-14

Spandidos Publications

Access to resources Recommend Favorite

HER1/EGFR tyrosine kinase inhibitors for the treatment of glioblastoma multiforme

By Raizer Jeffrey  

Journal of Neuro-Oncology, Vol. 74, Iss. 1, 2005-08 ,pp. : 77-86

Springer Publishing Company

Access to resources Recommend Favorite